1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid
C19H23F3N6O2S — CID 154924646
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid
1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid (PubChem CID 154924646) has the molecular formula C19H23F3N6O2S and a molecular weight of 456.49 g/mol. Its IUPAC name is 1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid.
Molecular Properties
| Compound Name | 1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid |
|---|---|
| PubChem CID | 154924646 |
| Molecular Formula | C19H23F3N6O2S |
| Molecular Weight | 456.49 g/mol |
| Exact Mass | 456.16 |
| IUPAC Name | 1-[(1-ethylpyrazol-4-yl)methyl]-4-(4-thiophen-3-yltriazol-1-yl)piperidine;2,2,2-trifluoroacetic acid |
| SMILES | CCn1cc(CN2CCC(n3cc(-c4ccsc4)nn3)CC2)cn1.O=C(O)C(F)(F)F |
| InChI | InChI=1S/C17H22N6S.C2HF3O2/c1-2-22-11-14(9-18-22)10-21-6-3-16(4-7-21)23-12-17(19-20-23)15-5-8-24-13-15;3-2(4,5)1(6)7/h5,8-9,11-13,16H,2-4,6-7,10H2,1H3;(H,6,7) |
| InChIKey | OPRBXNBQRAIQBN-UHFFFAOYSA-N |
| XLogP | 3.69 |
| TPSA | 89.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.49 |
| LogP ≤ 5 | 3.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154924646 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.